PCC Rokit (PCR) Q4 2024 earnings summary

Executive summary

• Consolidated EBITDA for 2024 was 374 million PLN, down 28% year-over-year, reflecting a challenging market environment and lower segment results, especially in chlorinated derivatives.

• Net profit reached 143.1 million PLN, a 47% decrease compared to 2023, following a historically strong prior year.

• Revenue for 2024 totaled 1.95 billion PLN, an 18% decline from 2023.

• Investment projects continued, including ongoing CAPEX in production and infrastructure.

Financial highlights

• EBITDA: 374 million PLN in 2024, down from 519 million PLN in 2023.

• Net profit: 143.1 million PLN, down 47% year-over-year.

• Revenue: 1.95 billion PLN, down 18% from 2023.

• Net debt at year-end: 390 million PLN; Net debt/EBITDA ratio at 1.0.

• ROE: 10.3%; ROA: 5.7% for 2024.

Outlook and guidance

• Market conditions remain demanding, especially for chlorinated derivatives, with uncertain price trends for caustic soda and lye.

• The company expects continued challenges in construction and chemical markets, requiring operational flexibility.